Upgrade to SI Premium - Free Trial

Quest Diagnostics (DGX) PT Raised to $160 at Jefferies

July 23, 2021 8:44 AM
Jefferies analyst Brian Tanquilut raised the price target on Quest Diagnostics (NYSE: DGX) to $160.00 (from $155.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles